Use of genomics to balance cure and complications
Crossref DOI link: https://doi.org/10.1038/s41571-019-0306-1
Published Online: 2019-11-29
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Azria, David
Rosenstein, Barry S. http://orcid.org/0000-0002-3149-3237
Text and Data Mining valid from 2019-11-29
Version of Record valid from 2019-11-29
Article History
First Online: 29 November 2019
Competing interests
: David Azria is a founder of NovaGray. B.R. declares no competing interests.